Global /China /Healthcare /Drug Manufacturers - General /002872

Tiansheng Pharmaceutical Group Co., Ltd.

002872

• SHE: 002872 • Delayed

5.42CNY -0.4%

0.8009 USD

As of 16 June 2026, Tiansheng Pharmaceutical Group Co., Ltd. has a market cap of $255.63M USD, ranking #19567 globally and #5659 in China. It ranks #1756 in the Healthcare sector, and #640 in the Drug Manufacturers - General industry.

Global Rank

19567

Country Rank

5659

Sector Rank

1756

Industry Rank

640

Key Stats

Market Cap

$255.63MUSD

1.73B CNY

Enterprise Value

$268.39MUSD

1.82B CNY

Revenue (TTM)

$75.97MUSD

514.09M CNY

EBITDA (TTM)

$12.23MUSD

82.74M CNY

Net Income (TTM)

-$8.19MUSD

-55.42M CNY

EBITDA Margin

16%

Profit Margin

-11%

PS Ratio

3.4

PB Ratio

0.9

EV/EBITDA

19.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Shuang Liu open_in_new

Employees

1,272

Founded

2001

Website

tszy.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.4%	9.9%	5%	12%	7.5%	12%	39%	0.6%	18%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002872 天圣制药集团股份有限公司 Class A ISIN: CNE100002QC3 Shares Out.: Shares Outstanding: 318.0M¹ Shares Float: 317.989M² TV: TradingView: SZSE: 002872 SA: Stock Analysis: SHE: 002872 YF: Yahoo Finance: 002872.SZ GF: Google Finance: SHE: 002872 BA: Barron's: 002872 MS: Morningstar: XSHE: 002872	5.42 CNY	TV: TradingView: SZSE: 002872 SA: Stock Analysis: SHE: 002872 YF: Yahoo Finance: 002872.SZ GF: Google Finance: SHE: 002872 BA: Barron's: 002872 MS: Morningstar: XSHE: 002872

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tiansheng Pharmaceutical Group Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, gynecological, orthopedic, cardiology, diabetes, anesthetic, and others. It also provides traditional Chinese medicines and glucose injection. The company was founded in 2001 and is headquartered in Chongqing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.92B 364.89B CNY 21K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.7B 336.36B CNY 19K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 11K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 7K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 6K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 6K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 298K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 214K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 141K%	97.4	United States
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 125K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 113K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 107K%	15.1	United States

chevron_leftBack